HIGHLIGHTS
- who: Shu-jen Chen from the AML patient samples were obtained from the Institute of Personalized Medicine (IPM) at the Pennsylvania State University College of Medicine under protocols approved by the Institutional Review BoardConsent was obtained at sample collection by the IPM tumor bank and was not required for this study by the Institutional Review Board have published the Article: Transient receptor potential ion channel TRPM2 promotes AML proliferation and survival through modulation of mitochondrial function, ROS, and autophagy, in the Journal: (JOURNAL)
- what: The authors show that TRPM2 is highly expressed in acute myeloid . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.